Thousands of unvaccinated adults die each year from preventable diseases

February 4, 2014

While adults make up 95 percent of those who die annually from vaccine preventable diseases, a new study from the University of Colorado School of Medicine shows their vaccination rates remain stubbornly low, representing a growing public health concern.

The study, published recently in the Annals of Internal Medicine, is the first to examine several important aspects of adult vaccination. Every year, 30,000 people on average die of preventable illnesses, almost all of them adult.

"Our study suggests that missed opportunities for adult vaccination are common because vaccination status is not being assessed at every (physician's) visit, which is admittedly an ambitious goal," said Laura Hurley, MD, MPH lead author of the study and an assistant professor of medicine at the CU School of Medicine. "Also, most physicians are not stocking all recommended vaccines."

Recent estimates show only 62 to 65 percent of adults aged 65 and older received a pneumococcal or respectively; just 20 percent of high risk adults between 19 and 64 received a and only 16 percent of those 60 and older got their herpes zoster (shingles) vaccination.

Hurley and her fellow researchers designed a national survey of in collaboration with the Centers for Disease Control and Prevention looking at how doctors assessed vaccination status and stocked the 11 recommended adult vaccines in 2012.

"Physicians reported a variety of barriers to vaccine stocking and administration but financial barriers dominated the list," the study said. "Physicians in smaller, private practice often assume more risks from stocking expensive vaccine inventories and may be particularly affected by these financial barriers."

According to Hurley, who also practices at Denver Health, many doctors expressed difficulty getting reimbursed by insurance for vaccines.

For example, the has been recommended since 2008 but is not widely stocked by physicians. One major reason for this, the study says, is that zoster is covered by Medicare Part D, a pharmaceutical benefit, and physicians report problems with reimbursement. At the same time, the vaccine can require substantial out-of-pocket costs for patients, making it less attractive to them as well.

As a result of these difficulties, many physicians are referring patients to pharmacies or public health facilities for vaccinations.

"The most commonly reported reasons for referring patients elsewhere for vaccines included insurance not covering the vaccine," the study said.

There were also problems coordinating vaccine records when done by someone who is not the patient's primary care physician.

The study makes recommendations for improving the overall situation.

It suggests using Immunization Information Systems or IIS, a confidential database that records all vaccine doses administered by providers in a certain area. The system can allow doctors to know the of their patients.

The authors point out that the Affordable Care Act addresses financial barriers to vaccination for privately insured patients by requiring insurers to cover recommended vaccines with no co-pays when delivered by in-network providers. There have also been recommendations for legislative action aimed at making Medicare Part D less of an obstacle to adult vaccinations.

"I feel we need to take a more systematic approach to this issue," Hurley said. "As the population ages this could easily grow into a more serious issue."

Explore further: ACIP announces recommended 2013 adult immunization schedule

Related Stories

ACIP announces recommended 2013 adult immunization schedule

January 28, 2013

The Center for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) announced its recommended 2013 adult immunization schedule that includes important updates to the pneumococcal, Tdap (tetanus, ...

Healthy doctors make healthy patients, study finds

April 8, 2013

Patients are more likely to follow preventive health practices like getting a flu shot or mammography if their doctors do likewise, researchers at the University of British Columbia and in Israel have discovered.

Recommended for you

Bile acid uptake inhibitor prevents NASH / fatty liver in mice

September 21, 2016

Drugs that interfere with bile acid recycling can prevent several aspects of NASH (nonalcoholic steatohepatitis) in mice fed a high-fat diet, scientists from Emory University School of Medicine and Children's Healthcare of ...

New therapeutic target for Crohn's disease

September 20, 2016

Research from the Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a promising new target for future drugs to treat inflammatory bowel disease (IBD). The study, published today in Cell Reports, also indicates ...

Mosquitoes, Zika and biotech regulation

September 19, 2016

In a new Policy Forum article in Science, NC State professor Jennifer Kuzma argues that federal authorities are missing an opportunity to revise outdated regulatory processes not fit for modern innovations in biotechnology, ...

Arthritis drug may help with type of hair loss

September 22, 2016

(HealthDay)—For people who suffer from a condition that causes disfiguring hair loss, a drug used for rheumatoid arthritis might regrow their hair, a new, small study suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.